Engineering Food and Drug Administration Pharmaceutical products 
European Pharmaceutical Review
MARCH 12, 2024
In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. What are three current key trends in data integrity? Ensuring data integrity in the life science industry is crucial for regulatory compliance.
Pharma Marketing Network
OCTOBER 1, 2024
By understanding these strategies, stakeholders in the pharmaceutical industry can better navigate the complexities of promoting their products effectively. Evolution of Marketing in the Pharmaceutical Industry The marketing of pharmaceutical products has undergone significant changes over the decades.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
OCTOBER 3, 2024
Understanding Pharmaceutical Marketing Dynamics Pharmaceutical marketing dynamics are shaped by a myriad of factors, including the rapidly evolving healthcare landscape, technological advancements, and shifting consumer expectations. It should be clear, concise, and aligned with the brand’s overall mission and values.
Pharmaceutical Technology
APRIL 26, 2023
The list also contains companies providing regulatory services, validations, package design verification testing, quality and microbial testing as well as different products, such as sterile barrier pouches and rigid trays for sterile implants, blister packages, strip packages, vials, ampoules, caps, bottles, desiccants and more.
European Pharmaceutical Review
AUGUST 23, 2022
The prevalence of fake drugs is a continually growing problem worldwide. Fake drugs can be categorised as substandard, falsified, counterfeit and diverted drugs, and the World Health Organization (WHO) broadly defines a counterfeit medicine as “one which is deliberately and fraudulently mislabelled with respect to identity and/or source.”
European Pharmaceutical Review
APRIL 8, 2025
They should remain informed, knowledgeable of the PAT, monitor compliance regularly, especially if PAT is directly involved in drug substance production and the instruments are product-contact and in the regulatory filing dossier. He is currently pursuing a masters in biopharmaceutical engineering at University College Dublin.
Expert insights. Personalized for you.
98 
Let's personalize your content